Mingzi Q. Tan

No. 36 Sanhao Street, Heping District, P.R. China
Shenyang, 110004, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Retraction Note: Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells.

Retraction Note: Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells.

Journal: Molecular cancer
Published: August 28, 2026

Nanotechnology-Assisted Co-Delivery of Immunotherapeutic Agents for Targeting Ovarian Cancer: Prospects and Challenges.

Nanotechnology-Assisted Co-Delivery of Immunotherapeutic Agents for Targeting Ovarian Cancer: Prospects and Challenges.

Journal: International journal of nanomedicine
Published: February 17, 2026

CPE/HYOU1 axis-activated Hippo-YAP signaling pathway suppresses PANoptosis to facilitate osteosarcoma progression.

CPE/HYOU1 axis-activated Hippo-YAP signaling pathway suppresses PANoptosis to facilitate osteosarcoma progression.

Journal: Cancer letters
Published: May 08, 2025

WDR3 undergoes phase separation to mediate the therapeutic mechanism of Nilotinib against osteosarcoma.

WDR3 undergoes phase separation to mediate the therapeutic mechanism of Nilotinib against osteosarcoma.

Journal: Journal of experimental & clinical cancer research : CR
Published: May 07, 2025

Development and validation of a nomogram for predicting overall and cancer-specific survival in elderly patients (≥ 65 years) with epithelial ovarian cancer.

Development and validation of a nomogram for predicting overall and cancer-specific survival in elderly patients (≥ 65 years) with epithelial ovarian cancer.

Journal: European journal of medical research
Published: September 30, 2024

A methylation-driven genes prognostic signature and the immune microenvironment in epithelial ovarian cancer.

A methylation-driven genes prognostic signature and the immune microenvironment in epithelial ovarian cancer.

Journal: Carcinogenesis
Published: February 15, 2022

Decreased PTGDS Expression Predicting Poor Survival of Endometrial Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Immunohistochemical Validation.

Decreased PTGDS Expression Predicting Poor Survival of Endometrial Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Immunohistochemical Validation.

Journal: Cancer management and research
Published: March 27, 2020

Inhibition of miR-182-5p attenuates pulmonary fibrosis via TGF-β/Smad pathway.

Inhibition of miR-182-5p attenuates pulmonary fibrosis via TGF-β/Smad pathway.

Journal: Human & experimental toxicology
Published: December 31, 2019

Estrogen/estrogen receptor promotes the proliferation of endometrial carcinoma cells by enhancing hMOF expression.

Estrogen/estrogen receptor promotes the proliferation of endometrial carcinoma cells by enhancing hMOF expression.

Journal: Japanese journal of clinical oncology
Published: July 31, 2019

Corrigendum to "Expression of HE4 in Endometrial Cancer and Its Clinical Significance".

Corrigendum to "Expression of HE4 in Endometrial Cancer and Its Clinical Significance".

Journal: BioMed research international
Published: July 17, 2018

High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer.

High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: July 04, 2017

c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer.

c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer.

Journal: Oncology reports
Published: April 23, 2017
Showing 1-12 of 30

Last Updated: 09/26/2026